Treatment for acute promyelocytic leukemia patients has improved by leaps and bounds. Dr. Daniel DeAngelo, Clinical Director for Adult Leukemia at the Hematologic Oncology Treatment Center, discusses ways that patients can address post-treatment concerns, such as recurrence and possible
